In a breakthrough study published in Nature, researchers have unveiled how lifestyle factors such as sleep and exercise distinctly influence clonal haematopoiesis (CH)—a condition characterized by the expansion of blood cell clones carrying somatic mutations, which is known to elevate inflammation and escalate cardiovascular risks like atherosclerosis. This investigation elucidates the mutation-dependent variability in CH responses to lifestyle interventions, providing a new dimension of understanding about how behavioral factors modulate the biology of mutant blood cells and the progression of cardiovascular disease.
The study systematically examined mutations in critical genes implicated in CH—Jak2, Tet2, Trp53, and Dnmt3a—using both human population data and sophisticated murine models. Previous evidence established that CH fuels systemic inflammation, but the extent to which lifestyle habits might modulate the expansion of these mutant clones or affect their pathological programming remained unexplored. This research bridges that gap by revealing that the effects of sleep and physical activity are not uniform but highly dependent on the specific genetic mutation driving the CH clone.
Epidemiological analyses of two independent human cohorts demonstrated a striking inverse association between moderate-to-vigorous physical activity and the prevalence of CH clones, especially those not driven by DNMT3A mutations. This suggests an innate sensitivity of certain mutant clones to the benefits of exercise, setting the stage for targeted lifestyle interventions in CH-affected individuals. Remarkably, this protective association was mutation-specific, underscoring the complexity of host-environment interactions in hematopoietic cell dynamics.
Leveraging genetically engineered mice predisposed to atherosclerosis, the researchers dissected the influence of uninterrupted sleep and consistent exercise on CH clone expansion across the four mutation models. They found that both sleep and exercise effectively curtailed clone expansion in mice harboring Jak2^V617F or Tet2 loss-of-function mutations, but not in those with Trp53 loss-of-function or Dnmt3a^R878H mutations. This reveals a fascinating gene-by-environment interplay where lifestyle factors modulate mutant cell proliferation in a mutation-dependent manner.
Delving deeper into the mechanistic details, the team uncovered that in Jak2^V617F mutant CH, lifestyle-induced benefits arise from the selective metabolic and transcriptional reprogramming of mutant hematopoietic progenitor cells, sparing their cohabitant wild-type counterparts. This reprogramming drives an antiproliferative state and a shift towards metabolically healthy phenotypes, principally through attenuation of the IL-1β signaling axis between bone marrow macrophages and progenitor cells. This pathway suppression effectively tempers mutant clone expansion, highlighting a novel conduit whereby behavioral cues influence hematopoietic stem cell biology.
Intriguingly, lifestyle interventions go beyond merely constraining clone expansion. Both sleep and exercise independently suppressed atherosclerotic burden in Jak2^V617F, Tet2 LOF, and Trp53 LOF mutant mice, while conspicuously failing to affect Dnmt3a^R878H-driven disease. This divergence pointed to an additional dimension of mutation-specificity, where local immune cell reprogramming within the vascular niche plays a pivotal role in attenuating lesion formation, independent of circulating mutant clone dynamics.
Within the vascular microenvironment, Jak2^V617F mutant macrophages showed diminished inflammasome activation upon uninterrupted sleep due to downregulation of CLEC4E—a critical receptor mediating inflammatory signaling cascades. This selective dampening of inflammasome activity curbs pro-atherosclerotic inflammation and lesion progression specifically in mutant macrophages, providing a rare example of mutation-specific immune modulation by a lifestyle factor.
Parallelly, exercise was found to potentiate activation of PAC1-positive neurons in the locus coeruleus, an unexpected neuro-immune link that elevated peripheral noradrenaline levels. The increased adrenergic signaling targets β2-adrenergic receptors (ADRβ2) expressed predominantly on Jak2^V617F mutant aortic macrophages, whose receptor expression is preserved by physical activity. This selective adrenergic repression of inflammatory programming in mutant cells, but not wild-type macrophages, underscores a sophisticated mechanism where the nervous system modulates mutation-specific immune responses, ultimately mitigating atherosclerosis.
These findings collectively indicate that the benefits of healthy lifestyle habits in CH are mechanistically multi-layered, involving direct reprogramming of mutant hematopoietic progenitors and mutation-specific modulation of inflammatory pathways in tissue-resident macrophages. The preservation of receptor expression and signaling capacities in mutant cells, and their sensitivity to systemic behavioral cues, open new possibilities for leveraging lifestyle as a modality for personalized CH management.
The implications of this research are profound, as they suggest that clinicians might one day incorporate patient-specific mutation profiling to tailor lifestyle recommendations that optimally suppress CH clone expansion and its vascular consequences. Moreover, by delineating the molecular circuits that mediate these effects, the study sets the stage for novel pharmacological strategies that mimic or potentiate the beneficial reprogramming elicited by sleep and exercise.
Despite the clear benefits elucidated, the study also highlights that some CH mutations, notably Dnmt3a^R878H, remain resilient to lifestyle modulation, signaling the need for mutation-specific therapeutic approaches. Future research must unravel why particular clones resist behavioral influences and how to overcome this resistance to deliver comprehensive cardiovascular protection.
This paradigm-shifting work establishes that the interplay between somatic mutations in hematopoietic cells and lifestyle factors is far from binary; instead, it embodies a complex gene-environment dialogue capable of reprogramming cells and modulating disease trajectories. As CH has emerged as a significant contributor to aging-associated inflammation and atherosclerosis, these insights carry substantial promise for public health and individualized medicine.
Ultimately, this study challenges the traditional notion that lifestyle exerts uniform systemic effects, revealing instead a nuanced mutation-dependent sensitivity that modulates both clonal hematopoiesis and vascular inflammation. It propels forward the concept that “healthy habits” possess a molecular specificity, selectively reining in pathogenic clones and steering immune cells towards cardiovascular health.
As the field advances, integrating genetic screening with lifestyle interventions may become a powerful axis in preventing and mitigating CH-driven pathology. The synergy of behavioral and molecular medicine illuminated here accentuates a future where gene-informed lifestyle optimization could redefine cardiovascular disease prevention.
Subject of Research: Mutation-dependent effects of sleep and exercise on clonal haematopoiesis and atherosclerosis.
Article Title: Mutation-dependent responses to sleep and exercise in clonal haematopoiesis.
Article References:
Gerhardt, T., Jacob, W., Gaebel, L. et al. Mutation-dependent responses to sleep and exercise in clonal haematopoiesis. Nature (2026). https://doi.org/10.1038/s41586-026-10634-0
Image Credits: AI Generated
